RespireRx Pharmaceuticals Inc. Purchase Agreements
24 Contracts & Agreements
- Securities Purchase Agreement dated April 14, 2022, between RespireRx Pharmaceuticals Inc. and Barton Asset Management LLC (Filed With SEC on April 15, 2022)
- Securities Purchase Agreement, dated July 29, 2009, by and between the Company and the Investors named therein (Filed With SEC on October 14, 2020)
- Asset Purchase Agreement, dated March 15, 2011, by and between the Company and Biovail Laboratories International SRL (Filed With SEC on October 14, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on October 14, 2020)
- Securities Purchase Agreement, dated April 24, 2019, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)
- Securities Purchase Agreement, dated May 17, 2019, between RespireRx Pharmaceuticals Inc. and Crown Bridge Partners, LLC (Filed With SEC on October 14, 2020)
- Securities Purchase Agreement, dated August 19, 2019, between RespireRx Pharmaceuticals Inc. and FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)
- Securities Purchase Agreement, dated October 22, 2019, between RespireRx Pharmaceuticals Inc. and EMA Financial, LLC (Filed With SEC on October 14, 2020)
- Securities Purchase Agreement, dated November 4, 2019, between RespireRx Pharmaceuticals Inc. and Odyssey Funding, LLC (Filed With SEC on October 14, 2020)
- Securities Purchase Agreement, dated April 15, 2020, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)
- Securities Purchase Agreement, dated June 7, 2020, between RespireRx Pharmaceuticals Inc. and Power Up Lending Group Ltd (Filed With SEC on October 14, 2020)
- Securities Purchase Agreement, dated July 2, 2020, between RespireRx Pharmaceuticals Inc. and FirstFire Global Opportunities Fund, LLC (Filed With SEC on October 14, 2020)
- Equity Purchase Agreement, dated July 28, 2020, between RespireRx Pharmaceuticals Inc. and White Lion Capital, LLC (Filed With SEC on October 14, 2020)
- Securities Purchase Agreement, dated July 30, 2020, between RespireRx Pharmaceuticals Inc. and EMA Financial, LLC (Filed With SEC on October 14, 2020)
- CORTEX PHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 16, 2012)
- CORTEX PHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 30, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 7, 2011)
- ASSET PURCHASE AGREEMENT BY AND BETWEEN BIOVAIL LABORATORIES INTERNATIONAL SRL, AS BUYER, AND CORTEX PHARMACEUTICALS, INC., AS SELLER TABLE OF CONTENTS (Filed With SEC on May 17, 2010)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 30, 2009)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 17, 2009)
- CORTEX PHARMACEUTICALS, INC. 5,021,427 Shares Warrants to Purchase 3,263,927 Shares (Filed With SEC on January 19, 2007)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 20, 2004)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 13, 2004)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 22, 2003)
